References
- WHO. Coronavirus disease (COVID-19) Situation Report-108 [7 May 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
- Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019 Mar;17(3):181–192. doi: 10.1038/s41579-018-0118-9
- National Health Commission of the People’s Republic of China. The Guidelines for Diagnosis and Treatment of Novel Coronavirus Pneumonia (7th version): National Health Commission of China; [7 May 2020]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
- Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389. doi: 10.1080/22221751.2020.1729071
- Liu R, Han H, Liu F, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020 Jun;505:172–175. doi: 10.1016/j.cca.2020.03.009
- Li Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020 Jul;92(7):903–908. doi: 10.1002/jmv.25786
- Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020 Jun 25;58(7):1070–1076. doi: 10.1515/cclm-2020-0285
- Wolfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020 May;581(7809):465–469. doi: 10.1038/s41586-020-2196-x
- Li G, Chen X, Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med. 2003 Jul 31;349(5):508–509. doi: 10.1056/NEJM200307313490520
- Chen Y, Chen L, Deng Q, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020 Jul;92(7):833–840. doi: 10.1002/jmv.25825
- Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 Jun;26(6):845–848. doi: 10.1038/s41591-020-0897-1
- Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020 Mar 28;ciaa344.
- Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020 Jul 28;71(15):778–785. doi: 10.1093/cid/ciaa310
- Lynch KL, Whitman JD, Lacanienta NP, et al. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity. Clin Infect Dis. 2020 Jul 14;ciaa979.
- Chen S, Lu D, Zhang M, et al. Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum. Eur J Clin Microbiol Infect Dis. 2005 Aug;24(8):549–553. doi: 10.1007/s10096-005-1378-7
- Burbelo PD, Riedo FX, Morishima C, et al. Sensitivity in detection of antibodies to nucleocapsid and spike Proteins of severe acute respiratory syndrome coronavirus 2 in patients With coronavirus disease 2019. J Infect Dis. 2020 Jun 29;222(2):206–213. doi: 10.1093/infdis/jiaa273
- Liu W, Liu L, Kou G, et al. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol. 2020 May 26;58(6):e00461–20. doi: 10.1128/JCM.00461-20
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020 Feb 7;323(11):1061. doi: 10.1001/jama.2020.1585
- Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020 Mar 17;10.1002/jmv.25767.
- Wang K, Zuo P, Liu Y, et al. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China. Clin Infect Dis. 2020 May 3:ciaa538. doi: 10.1093/cid/ciaa538
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3
- Shen L, Wang C, Zhao J, et al. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression. Emerg Microbes Infect. 2020 Dec;9(1):1096–1101. doi: 10.1080/22221751.2020.1766382
- Kong WH, Zhao R, Zhou JB, et al. Serologic response to SARS-CoV-2 in COVID-19 patients with different severity. Virol Sin. 2020 Jul 23;1–6.
- Sun B, Feng Y, Mo X, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):940–948. doi: 10.1080/22221751.2020.1762515
- Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020 Mar 19;382(12):1177–1179. doi: 10.1056/NEJMc2001737
- To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020 May;20(5):565–574. doi: 10.1016/S1473-3099(20)30196-1
- Corman VM, Albarrak AM, Omrani AS, et al. Viral shedding and antibody response in 37 patients With Middle East respiratory syndrome coronavirus infection. Clin Infect Dis. 2016 Feb 15;62(4):477–483.
- Gemmati D, Bramanti B, Serino ML, et al. COVID-19 and Individual Genetic Susceptibility/receptivity: role of ACE1/ACE2 genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in females Be Protective against SARS-CoV-2 compared to the single X-Chromosome in males? Int J Mol Sci. 2020 May 14;21(10):3474. doi: 10.3390/ijms21103474